Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1466744016 | Oral cyclophosphamide (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1486541016 | Oral cyclophosphamide | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2153761010 | Oral form cyclophosphamide (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2161308014 | Oral form cyclophosphamide | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3490524012 | Product containing cyclophosphamide in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3494673016 | Product containing cyclophosphamide in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3494674010 | Cyclophosphamide in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3709396015 | Product containing cyclophosphamide in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3709397012 | Cyclophosphamide-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing cyclophosphamide in oral dose form (medicinal product form) | Is a | Product containing cyclophosphamide | true | Inferred relationship | Existential restriction modifier | ||
| Product containing cyclophosphamide in oral dose form (medicinal product form) | Has active ingredient | Cyclophosphamide | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing cyclophosphamide in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing cyclophosphamide in oral dose form (medicinal product form) | Is a | Product manufactured as oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing cyclophosphamide in oral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely cyclophosphamide 50 milligram/1 each conventional release oral tablet | Is a | False | Product containing cyclophosphamide in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely cyclophosphamide 25 milligram/1 each conventional release oral tablet | Is a | False | Product containing cyclophosphamide in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only cyclophosphamide in oral dose form (medicinal product form) | Is a | True | Product containing cyclophosphamide in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR